Clinical Trial Update: A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein). [NA]

View source ↗

Summary

A single-center, cross-sectional study in people with multiple sclerosis investigates different types of cognitive impairment and cerebrospinal fluid biomarkers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Nantes University Hospital | Conditions: Disseminated Sclerosis | NA | Status: TERMINATED